Grace Therapeutics, Inc. (ACST)

2.12 +0.02 (+0.95%) USD  |  NASDAQ  |  Sep 08, 16:00
More

Grace Therapeutics EV to CFO

EV to CFO Chart

View EV to CFO for ACST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to CFO Chart
Start Trial

Historical EV to CFO Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
December 31, 2025 --
September 30, 2025 --
Date Value
June 30, 2025 --
March 31, 2025 --
December 31, 2024 --

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
AbbVie, Inc. Upgrade
Abeona Therapeutics, Inc. Upgrade
America Great Health Upgrade
Acumen Pharmaceuticals, Inc. Upgrade
Aardvark Therapeutics, Inc. Upgrade

EV to CFO Related Metrics

EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade